ziptides tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says How the weight loss drug

This is not a concern at standard dosages (1040 mcg/day) for under 8 weeks, but should be avoided by those with a history of cancer or uncontrolled growth conditions

This risk may be compounded if GLP-1 receptor agonists cause dehydration through gastrointestinal side effects

The SmPC notes an increased risk of gallbladder events with semaglutide treatment

For example, if the initial benefits wane, the dosage or frequency of injections may need to be adjusted

If you are insured, your provider can assist with insurance pre-authorization paperwork to help reduce the cost of your medication

Diabetes Technology & Therapeutics , 13(7), 735-742.